DOD Biotech PCL (BKK:DOD-R) Change In Receivables : ฿36.7 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Change In Receivables?

DOD Biotech PCL's change in receivables for the quarter that ended in Mar. 2025 was ฿-23.9 Mil. It means DOD Biotech PCL's Accounts Receivable increased by ฿23.9 Mil from Dec. 2024 to Mar. 2025 .

DOD Biotech PCL's change in receivables for the fiscal year that ended in Dec. 2024 was ฿89.6 Mil. It means DOD Biotech PCL's Accounts Receivable declined by ฿89.6 Mil from Dec. 2023 to Dec. 2024 .

DOD Biotech PCL's Accounts Receivable for the quarter that ended in Mar. 2025 was ฿48.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. DOD Biotech PCL's Days Sales Outstanding for the three months ended in Mar. 2025 was 26.02.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. DOD Biotech PCL's liquidation value for the three months ended in Mar. 2025 was ฿136.0 Mil.

DOD Biotech PCL Change In Receivables Historical Data

The historical data trend for DOD Biotech PCL's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Change In Receivables Chart

DOD Biotech PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-67.33

-66.10

-124.57

-43.44

89.58

DOD Biotech PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															28.96	33.10	9.35	18.17	-23.89

DOD Biotech PCL Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿36.7 Mil.

DOD Biotech PCL (BKK:DOD-R) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

DOD Biotech PCL's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	48.777	/	171.066	*	91
=	26.02

2. In Ben Graham's calculation of liquidation value, DOD Biotech PCL's accounts receivable are only considered to be worth 75% of book value:

DOD Biotech PCL's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	223.074	-	173.077	+	0.75 * 48.777	+	0.5 * 98.741
=	136.0

DOD Biotech PCL Change In Receivables Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

DOD:Thailand

Address

No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines